{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:50Z","timestamp":1753891010227,"version":"3.41.2"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>An effective malaria vaccine must prevent disease in a range of populations living in regions with vastly different transmission rates and protect against genetically-diverse<jats:italic>Plasmodium falciparum<\/jats:italic>(Pf) strains. The protective efficacy afforded by the currently licensed malaria vaccine, Mosquirix\u2122, promotes strong humoral responses to Pf circumsporozoite protein (CSP) 3D7 but protection is limited in duration and by strain variation. Helper CD4 T cells are central to development of protective immune responses, playing roles in B cell activation and maturation processes, cytokine production, and stimulation of effector T cells. Therefore, we took advantage of recent in silico modeling advances to predict and analyze human leukocyte antigen (HLA)-restricted class II epitopes from PfCSP \u2013 across the entire PfCSP 3D7 sequence as well as in 539 PfCSP sequence variants \u2013 with the goal of improving PfCSP-based malaria vaccines. Specifically, we developed a systematic workflow to identify peptide sequences capable of binding HLA-DR in a context relevant to achieving broad human population coverage utilizing cognate T cell help and with limited T regulatory cell activation triggers. Through this workflow, we identified seven predicted class II epitope clusters in the N- and C-terminal regions of PfCSP 3D7 and an additional eight clusters through comparative analysis of 539 PfCSP sequence variants. A subset of these predicted class II epitope clusters was synthesized as peptides and assessed for HLA-DR binding<jats:italic>in vitro<\/jats:italic>. Further, we characterized the functional capacity of these peptides to prime and activate human peripheral blood mononuclear cells (PBMCs), by monitoring cytokine response profiles using MIMIC<jats:sup>\u00ae<\/jats:sup>technology (Modular IMmune<jats:italic>In vitro<\/jats:italic>Construct). Utilizing this decision framework, we found sufficient differential cellular activation and cytokine profiles among HLA-DR-matched PBMC donors to downselect class II epitope clusters for inclusion in a vaccine targeting PfCSP. Importantly, the downselected clusters are not highly conserved across PfCSP variants but rather, they overlap a hypervariable region (TH2R) in the C-terminus of the protein. We recommend assessing these class II epitope clusters within the context of a PfCSP vaccine, employing a test system capable of measuring immunogenicity across a broad set of HLA-DR alleles.<\/jats:p>","DOI":"10.3389\/fimmu.2021.689920","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T06:07:07Z","timestamp":1623132427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains"],"prefix":"10.3389","volume":"12","author":[{"given":"Amy R.","family":"Noe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances E.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Schanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Sassano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Phares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Moise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne M.","family":"Christen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayaka","family":"Kotraiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Donald R.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eaau1458","DOI":"10.1126\/scitranslmed.aau1458","article-title":"Challenges and Strategies for Developing Efficacious and Long-Lasting Malaria Vaccines","volume":"11","author":"Beeson","year":"2019","journal-title":"Sci Transl Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-Year Efficacy of RTS,S\/AS01 Malaria Vaccine Among Young African Children","volume":"374","author":"Olotu","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS,S\/AS01 Malaria Vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1086\/600120","article-title":"Randomized, Double-Blind, Phase 2a Trial of falciparum Malaria Vaccines RTS,S\/AS01B and RTS,S\/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1988.tb03104.x","article-title":"Human T Cells Recognize Polymorphic and Non-Polymorphic Regions of the Plasmodium falciparum Circumsporozoite Protein","volume":"7","author":"Guttinger","year":"1988","journal-title":"EMBO J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/360434a0","article-title":"Molecular Analysis of the Association of HLA-B53 and Resistance to Severe Malaria","volume":"360","author":"Hill","year":"1992","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.1.489","article-title":"CD4+ T Cell Clones Obtained From Plasmodium falciparum Sporozoite-Immunized Volunteers Recognize Polymorphic Sequences of the Circumsporozoite Protein","volume":"151","author":"Moreno","year":"1993","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240627","article-title":"Natural Amino Acid Polymorphisms of the Circumsporozoite Protein of Plasmodium falciparum Abrogate Specific Human CD4+ T Cell Responsiveness","volume":"24","author":"Zevering","year":"1994","journal-title":"Eur J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00514.x","article-title":"Human and Murine T-cell Responses to Allelic Forms of a Malaria Circumsporozoite Protein Epitope Support a Polyvalent Vaccine Strategy","volume":"94","author":"Zevering","year":"1998","journal-title":"Immunology"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.142.11.4000","article-title":"Human T Cell Recognition of Polymorphic Epitopes From Malaria Circumsporozoite Protein","volume":"142","author":"de Groot","year":"1989","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-2494(94)80178-9","article-title":"Effect of Polymorphism of Sporozoite Antigens on T-cell Activation","volume":"145","author":"Zevering","year":"1994","journal-title":"Res Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1061159","article-title":"Ivax: An Integrated Toolkit for the Selection and Optimization of Antigens and the Design of Epitope-Driven Vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-010-0435-2","article-title":"Design and Utilization of Epitope-Based Databases and Predictive Tools","volume":"62","author":"Salimi","year":"2010","journal-title":"Immunogenetics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-010-0067-0","article-title":"CD4+ T Cell Epitope Discovery and Rational Vaccine Design","volume":"58","author":"Rosa","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12936-016-1098-8","article-title":"Measurement of Ex Vivo ELISpot Interferon-Gamma Recall Responses to Plasmodium falciparum AMA1 and CSP in Ghanaian Adults With Natural Exposure to Malaria","volume":"15","author":"Ganeshan","year":"2016","journal-title":"Malar J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1039\/c7mb00332c","article-title":"An Immunoinformatics Approach to Promiscuous Peptide Design for the Plasmodium falciparum Erythrocyte Membrane Protein-1","volume":"13","author":"Khan","year":"2017","journal-title":"Mol Biosyst"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.046","article-title":"Promiscuous T-cell Epitopes of Plasmodium Merozoite Surface Protein 9 (PvMSP9) Induces IFN-gamma and IL-4 Responses in Individuals Naturally Exposed to Malaria in the Brazilian Amazon","volume":"28","author":"Lima-Junior","year":"2010","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511571200","article-title":"Major Histocompatibility Complex and T Cell Interactions of a Universal T Cell Epitope From Plasmodium falciparum Circumsporozoite Protein","volume":"281","author":"Parra-L\u00f3pez","year":"2006","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 Update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/imr.12740","article-title":"T Follicular Helper Cell Heterogeneity: Time, Space, and Function","volume":"288","author":"Song","year":"2019","journal-title":"Immunol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01795-18","article-title":"Viral Replicative Capacity, Antigen Availability Via Hematogenous Spread, and High T(Fh):T(Fr) Ratios Drive Induction of Potent Neutralizing Antibody Responses","volume":"93","author":"Eldi","year":"2019","journal-title":"J\u00a0Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e20200547","DOI":"10.1084\/jem.20200547","article-title":"CD4+ Follicular Regulatory T Cells Optimize the Influenza Virus-Specific B Cell Response","volume":"218","author":"Lu","year":"2021","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1123098","article-title":"T Cell Epitope Redundancy: Cross-Conservation of the TCR Face Between Pathogens and Self and its Implications for Vaccines and Autoimmunity","volume":"15","author":"Moise","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00477","article-title":"Targeting Regulatory T Cells to Improve Vaccine Immunogenicity in Early Life","volume":"5","author":"Ndure","year":"2014","journal-title":"Front Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0158-z","article-title":"T Cell-Mediated Immunity to Malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune Checkpoint Blockade in Infectious Diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00442","article-title":"Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools","volume":"11","author":"De Groot","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050594","article-title":"Nine Major HLA Class I Supertypes Account for the Vast Preponderance of HLA-A and -B Polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.7.3363","article-title":"Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires","volume":"160","author":"Southwood","year":"1998","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.07.001","article-title":"T Cell Epitope: Friend or Foe? Immunogenicity of Biologics in Context","volume":"61","author":"Weber","year":"2009","journal-title":"Adv Drug Delivery Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24615","article-title":"The Two-Faced T Cell Epitope: Examining the Host-Microbe Interface With Janusmatrix","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1560772","article-title":"Immune Escape and Immune Camouflage may Reduce the Efficacy of RTS,S Vaccine in Malawi","volume":"16","author":"Khan","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature16141","article-title":"A Mechanism for Expansion of Regulatory T-cell Repertoire and its Role in Self-Tolerance","volume":"528","author":"Feng","year":"2015","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2004.06.003","article-title":"Engineering Immunogenic Consensus T Helper Epitopes for a Cross-Clade HIV Vaccine","volume":"34","author":"De Groot","year":"2004","journal-title":"Methods"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052471","article-title":"Antibiotic-Refractory Lyme Arthritis is Associated With HLA-DR Molecules That Bind a Borrelia Burgdorferi Peptide","volume":"203","author":"Steere","year":"2006","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2008.02.021","article-title":"A Novel Approach for the Generation of Human Dendritic Cells From Blood Monocytes in the Absence of Exogenous Factors","volume":"335","author":"Schanen","year":"2008","journal-title":"J Immunol Methods"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.099","article-title":"The In Vitro MIMIC(R) Platform Reflects Age-Associated Changes in Immunological Responses After Influenza Vaccination","volume":"35","author":"Dauner","year":"2017","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00251-004-0647-4","article-title":"Definition of Supertypes for HLA Molecules Using Clustering of Specificity Matrices","volume":"55","author":"Lund","year":"2004","journal-title":"Immunogenetics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki357","article-title":"PEPVAC: A Web Server for Multi-Epitope Vaccine Development Based on the Prediction of Supertypic MHC Ligands","volume":"33","author":"Reche","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.009437","article-title":"Human Leukocyte Antigen (HLA) Class II Peptide Flanking Residues Tune the Immunogenicity of a Human Tumor-Derived Epitope","volume":"294","author":"MacLachlan","year":"2019","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15053","DOI":"10.1038\/s41598-017-15354-0","article-title":"Novel Plasmodium Antigens Identified Via Genome-Based Antibody Screen Induce Protection Associated With Polyfunctional T Cell Responses","volume":"7","author":"Schussek","year":"2017","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 Cells Define a Correlate of Vaccine-Mediated Protection Against Leishmania Major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s13337-013-0187-3","article-title":"Regulatory T Cells as Adjuvant Target for Enhancing the Viral Disease Vaccine Efficacy","volume":"25","author":"Bayry","year":"2014","journal-title":"Virusdisease"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.11.007","article-title":"Designer Adjuvants for Enhancing the Efficacy of Infectious Disease and Cancer Vaccines Based on Suppression of Regulatory T Cell Induction","volume":"122","author":"Mills","year":"2009","journal-title":"Immunol Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.02.001","article-title":"A CCR4 Antagonist Enhances DC Activation and Homing to the Regional Lymph Node and Shows Potent Vaccine Adjuvant Activity Through the Inhibition of Regulatory T-cell Recruitment","volume":"136","author":"Yamamoto","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"Pd-L1 Regulates the Development, Maintenance, and Function of Induced Regulatory T Cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 During Effector CD8 T Cell Differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01377","article-title":"A Peptide-Based Pd1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model","volume":"11","author":"Phares","year":"2020","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.154.8.3922","article-title":"Localization of HLA-A2.1-Restricted T Cell Epitopes in the Circumsporozoite Protein of Plasmodium falciparum","volume":"154","author":"Blum-Tirouvanziam","year":"1995","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1074-7613(00)80513-0","article-title":"Degenerate Cytotoxic T Cell Epitopes From P. falciparum Restricted by Multiple HLA-A and HLA-B Supertype Alleles","volume":"7","author":"Doolan","year":"1997","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5561","article-title":"Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization With Malaria DNA and Recombinant Protein","volume":"172","author":"Wang","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205737109","article-title":"Unexpected Fold in the Circumsporozoite Protein Target of Malaria Vaccines","volume":"109","author":"Doud","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.689920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T17:06:14Z","timestamp":1699117574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.689920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2021.689920"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.689920","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"article-number":"689920"}}